secwatch.observer — SEC 8-K summary
======================================

Issuer:     Whitehawk Therapeutics, Inc. (WHWK)
CIK:        0001422142
Form:       8-K
Filed at:   2024-08-22T23:59:59+00:00
Accession:  0001193125-24-205370
Event type: leadership
Sentiment:  negative
Materiality: 0.65
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

CMO Loretta Itri resigns; Executive Chairman Neil Desai steps down on Oct 1, 2024
--------------------------------------------------------------------------------

- CMO Dr. Loretta Itri voluntarily resigns effective Oct 1, 2024; receives 12 months severance pay plus COBRA reimbursement.
- Executive Chairman Neil Desai terminated effective Oct 1, 2024; receives severance per agreement; remains on board.
- Dr. Itri enters consulting arrangement: 10 hrs/month, $8,000 monthly retainer, initial 3-month term.
- Both executives continue vesting in equity awards during consulting/board service.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1422142/000119312524205370/0001193125-24-205370-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1422142/000119312524205370/d884557d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-205370

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer